Buffalo, NY USA
Add to Favorites | Newsroom RSS | Share

Our News on Newswise

Lieutenant Gov. Kathy Hochul Celebrates Launch of Innovative Immunotherapy Biotech Company Based in Buffalo

• New Roswell Park spinoff company will develop next-generation cancer immunotherapies • Novel approach combines unique adoptive T cell therapy with genetically engineered stem cell therapy • Clinical trial planned in ovarian, pancreatic,...
3-Feb-2017 12:05 PM EST Add to Favorites

More than a Quarter of U.S. Adults, Roughly 9 Percent of U.S. Youth Use Tobacco

BUFFALO, N.Y. — More than 1 in 4 adults and nearly 1 in 10 youth use tobacco, according to findings from the Population Assessment of Tobacco and Health (PATH) Study, published online ahead of print in the New England Journal of Medicine. The PATH...
24-Jan-2017 12:00 PM EST Add to Favorites

Can Prostate Cancer Metastasis Be Stopped Before It Starts? Research Team Identifies Role for Particular MicroRNA

Metastasis, or spread of a tumor from the site of origin to additional organs, causes the vast majority of cancer-related deaths, but our understanding of the molecular mechanisms behind metastasis remains limited. A research team led by Dean Tang,...
24-Jan-2017 9:05 AM EST Add to Favorites

Unique Gene Signature Predicts Potentially Lethal Prostate Cancers

Standard therapy for prostate cancer, the third-leading cause of cancer-related deaths in American men, is based on blocking androgens, the male sex hormones. However, for some men, prostate cancer recurs despite androgen-deprivation therapy. A team...
10-Jan-2017 2:05 PM EST Add to Favorites

Roswell Park Researchers Offer Novel Insight Into Genetic Changes Leading to Cancer

BUFFALO, N.Y. — Predisposition to cancer and cancer progression can result from gene mutations that cause elevated rates of genetic damage. Similarly, carcinogens, including some that are used in chemotherapy during cancer treatment, act by...
10-Jan-2017 11:05 AM EST Add to Favorites

New Study Highlights Role for Immune Cells in Cancer’s Ability to Evade Immunotherapy

One of the main reasons cancer remains difficult to treat is that cancer cells have developed a multitude of mechanisms that allow them to evade destruction by the immune system. One of these escape mechanisms involves a type of immune cell called...
29-Dec-2016 4:05 PM EST Add to Favorites

New Ovarian Cancer Immunotherapy Study Poses Question: Can Microbiome Influence Treatment Response?

EmeseZsirosinclinic.jpeg

A new clinical study underway at Roswell Park Cancer Institute is the first to test the combination of the immunotherapy pembrolizumab with two other drugs as treatment for recurrent epithelial ovarian cancer, and is also the first ovarian cancer...
28-Nov-2016 12:05 PM EST Add to Favorites

Roswell Park Gets FDA Approval for Clinical Study of Cuban Lung Cancer Vaccine, License for Joint U.S.–Cuba Commercial Partnership

cimavax-press-johnson_2.jpg

Spurred by NYS Trade Mission to Cuba in 2015, Buffalo cancer center will conduct a clinical trial with CIMAvax-EGF, groundbreaking immunotherapy for lung cancer developed in Cuba — becoming the first American center to receive FDA authorization to...
26-Oct-2016 2:05 PM EDT Add to Favorites

Our Experts on Newswise

Roswell Park: Racial Disparities From Cervical Cancer Are a Wake-Up Call

25-Jan-2017 10:05 AM EST

Dr. Igor Puzanov of @RoswellPark Cancer Institute Avail. To Comment on Chan/Zuckerberg $30b Pledge for #Medicalresearch

22-Sep-2016 3:05 PM EDT

Roswell Park's Dr. James Marshall Available to Interpret, Comment on Who Statement on Processed Meats and Cancer Risk

27-Oct-2015 5:05 PM EDT

Cancer-Specific Clinical Research Center: New Frontiers in Research at Roswell Park

Clinical trials are the frontier for targeted cancer drugs. Roswell Park Cancer Institute recently opened one of only a few clinical research centers in the U.S. focused exclusively on cancer. The Clinical Research Center, under the direction of...
4-Apr-2008 1:00 PM EDT

Our YouTube Videos

Youtube feed not yet configured. Is this your Newswise member page? Contact member@newswise.com to configure this module.




Chat now!